Researchers find hope in diabetes battle

September 16, 2006

Canadian researchers have found what they hope is a magic bullet in combating diabetes.

McMasters University scientists are crediting extra use by the commonly prescribed Rosiglitazone for the hope of cutting the diabetes epidemic in half, the Hamilton Spectator said.

Widely used to treat type 2 diabetes, Rosiglitazone has been found effective for those at highest risk because of genetics, age or obesity, making it what researchers call the first line of defense for diabetes.

The results of the $25 million study were presented Friday at the annual meeting of the European Association for the Study of Diabetes in Copenhagen.

Copyright 2006 by United Press International

Explore further: Researchers perform large genome-wide analysis of multiple sclerosis

Related Stories

Diabetes: new hope for better wound healing

October 10, 2016

A sluggish insulin metabolism results in the slow and incomplete healing of injuries. That is why diabetics often have to contend with wounds that heal poorly. Researchers at the Max Planck Institute for Biology of Ageing, ...

Quick test to detect inflammation in diabetic patients

September 27, 2016

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation.

Recommended for you


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.